Related references
Note: Only part of the references are listed.Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
James T. England et al.
BLOOD REVIEWS (2021)
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
Jose Maria Galvan-Roman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki et al.
CELL (2021)
Treg cell therapy: How cell heterogeneity can make the difference
Giulio Giganti et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Predictive immunogenetic markers in COVID-19
Mauro de Meira Leite et al.
HUMAN IMMUNOLOGY (2021)
Defining IL-6 levels in healthy individuals: A meta-analysis
Elias A. Said et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study
Sultan Mehmood Kamran et al.
PLOS ONE (2021)
TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
Gillina F. G. Bezemer et al.
FRONTIERS IN PHARMACOLOGY (2021)
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned
Varvara A. Ryabkova et al.
CLINICAL IMMUNOLOGY (2021)
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study
Marco Franzetti et al.
JOURNAL OF IMMUNOLOGY (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Alessio Danilo Inchingolo et al.
MICROORGANISMS (2021)
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome A single center experience from Pune, Western India
Ameet Dravid et al.
MEDICINE (2021)
Combination of natural antivirals and potent immune invigorators: A natural remedy to combat COVID-19
Muhammad Ajmal Shah et al.
PHYTOTHERAPY RESEARCH (2021)
The Mechanism behind Influenza Virus Cytokine Storm
Yinuo Gu et al.
VIRUSES-BASEL (2021)
Resveratrol supplementation reduces ACE2 expression in human adipose tissue
Marlies de Ligt et al.
ADIPOCYTE (2021)
Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae Seok Kim et al.
THERANOSTICS (2021)
Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)
Jia-Jie Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
Justin Stebbing et al.
SCIENCE ADVANCES (2021)
Regulatory B cells in infection, inflammation, and autoimmunity
Subhajit Dasgupta et al.
CELLULAR IMMUNOLOGY (2020)
Levels of pro- and anti-inflammatory cytokines in cystic fibrosis patients with or without gingivitis
Onurcem Duruel et al.
CYTOKINE (2020)
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
An immune-cell signature of bacterial sepsis
Miguel Reyes et al.
NATURE MEDICINE (2020)
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Aleksandra Petrovic Fabijan et al.
NATURE MICROBIOLOGY (2020)
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Ahmet Kursat Azkur et al.
ALLERGY (2020)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Dandan Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Wei Cao et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Cytokine Storms: Understanding COVID-19
Nilam Mangalmurti et al.
IMMUNITY (2020)
Selective inhibition of interleukin-1 receptor-associated kinase 1 ameliorates lipopolysaccharide-induced sepsis in mice
Bin Pan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
Zulvikar Syambani Ulhaq et al.
MEDICINA CLINICA (2020)
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
Lan Huang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
Raphael Cauchois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
Wei Luo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Apoptotic cell therapy for cytokine storm associated with acute severe sepsis
Netanel Karbian et al.
CELL DEATH & DISEASE (2020)
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi et al.
NATURE COMMUNICATIONS (2020)
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial
Fang Liu et al.
BMJ OPEN (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
Sujin Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach
Muhammad Usman Mirza et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets
V. Kumar
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19
W. Larry Gluck et al.
RESPIRATORY MEDICINE (2020)
Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19
Raman Kumar et al.
VIRUS RESEARCH (2020)
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Tsun-Yung Kuo et al.
SCIENTIFIC REPORTS (2020)
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome
Jiao Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations
In-Hee Lee et al.
INFECTION GENETICS AND EVOLUTION (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study
Bulent Gucyetmez et al.
CRITICAL CARE (2020)
Gpr174-deficient regulatory T cells decrease cytokine storm in septic mice
Dongze Qiu et al.
CELL DEATH & DISEASE (2019)
Diagnostic accuracy of a rapid RT-PCR assay for point-of-care detection of influenza A/B virus at emergency department admission: A prospective evaluation during the 2017/2018 influenza season
Maxime Maignan et al.
PLOS ONE (2019)
Role of the Innate Cytokine Storm Induced by the Influenza A Virus
Yinuo Gu et al.
VIRAL IMMUNOLOGY (2019)
Effects of early enteral nutrition on Th17/Treg cells and IL-23/IL-17 in septic patients
Jia-Kui Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection
Radha Gopal et al.
VIRUSES-BASEL (2019)
IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin directed vascular barrier disruption
Victoria Langer et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease
Motoko Koyama et al.
BLOOD (2019)
MiR-590-3p Attenuates Acute Kidney Injury by Inhibiting Tumor Necrosis Factor Receptor-Associated Factor 6 in Septic Mice
Jing Ma et al.
INFLAMMATION (2019)
Inhibition of autophagy protects against sepsis by concurrently attenuating the cytokine storm and vascular leakage
Liang-Hsuan Lu et al.
JOURNAL OF INFECTION (2019)
Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder
Martina Sgritta et al.
NEURON (2019)
Short or Long Antibiotic Regimes in Orthopaedics (SOLARIO): a randomised controlled open-label non-inferiority trial of duration of systemic antibiotics in adults with orthopaedic infection treated operatively with local antibiotic therapy
Maria Dudareva et al.
TRIALS (2019)
Metabolic Pathways Involved in Regulatory T Cell Functionality
Rosalie W. M. Kempkes et al.
FRONTIERS IN IMMUNOLOGY (2019)
Plasma proteomics identifies a chemokine storm' in idiopathic multicentric Castleman disease
Sheila K. Pierson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
Nuala J. Meyer et al.
CRITICAL CARE MEDICINE (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
Xi Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
Exotoxins and endotoxins: Inducers of inflammatory cytokines
Jean-Marc Cavaillon
TOXICON (2018)
Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock
M. Feuerecker et al.
SCIENTIFIC REPORTS (2018)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The clinical importance of a cytokine network in the acute phase of sepsis
Hisatake Matsumoto et al.
SCIENTIFIC REPORTS (2018)
Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy
Kevin A. Hay
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Inflammation induced by influenza virus impairs human innate immune control of pneumococcus
Simon P. Jochems et al.
NATURE IMMUNOLOGY (2018)
Cytokine storm and sepsis disease pathogenesis
Benjamin G. Chousterman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Cytokine storms in infectious diseases
John R. Teijaro
SEMINARS IN IMMUNOPATHOLOGY (2017)
Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
Edward M. Behrens et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment
Sigrun R. Hofmann et al.
CURRENT OSTEOPOROSIS REPORTS (2017)
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy
Kevin A. Hay et al.
BLOOD (2017)
The cytokine storm of severe influenza and development of immunomodulatory therapy
Qiang Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Immunotherapeutic implications of IL-6 blockade for cytokine storm
Toshio Tanaka et al.
IMMUNOTHERAPY (2016)
Understanding host-pathogen interaction
K. Asehnoune et al.
INTENSIVE CARE MEDICINE (2016)
Interactions between the microbiota and pathogenic bacteria in the gut
Andreas J. Baumler et al.
NATURE (2016)
Neutrophil trails guide influenza-specific CD8+ T cells in the airways
Kihong Lim et al.
SCIENCE (2015)
Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis
Georg F. Weber et al.
SCIENCE (2015)
Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection
Yanping Gong et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflammation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum
Lukas Martin et al.
PLOS ONE (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
TLR-2 and TLR-4 expression in monocytes of newborns with late-onset sepsis
Ana C. C. Redondo et al.
JORNAL DE PEDIATRIA (2014)
The effects of oral antibiotics on infection prophylaxis in traumatic wounds
Bulent Erbil et al.
ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Cytokine markers as predictors of type of respiratory infection in patients during the influenza season
John Patrick Haran et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2013)
Targeting the Cytokine Storm for Therapeutic Benefit
Riccardo V. D'Elia et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
Hai-Nv Gao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
Early Host Cell Targets of Yersinia pestis during Primary Pneumonic Plague
Roger D. Pechous et al.
PLOS PATHOGENS (2013)
IL-10-Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
Abhishek Das et al.
JOURNAL OF IMMUNOLOGY (2012)
Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome
Ping-bo Xu et al.
JOURNAL OF INFECTION (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
TLR2, TLR4 and the MYD88 Signaling Pathway Are Crucial for Neutrophil Migration in Acute Kidney Injury Induced by Sepsis
Angela Castoldi et al.
PLOS ONE (2012)
Multiplex cytokine profiling in patients with sepsis
Simona Mera et al.
APMIS (2011)
Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection
John R. Teijaro et al.
CELL (2011)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Mzia Kutateladze et al.
TRENDS IN BIOTECHNOLOGY (2010)
Host-pathogen interactions in sepsis
Tom van der Poll et al.
LANCET INFECTIOUS DISEASES (2008)
Novel approaches to developing new antibiotics for bacterial infections
A. R. M. Coates et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The advent of the cytokine storm
Ian A. Clark
IMMUNOLOGY AND CELL BIOLOGY (2007)
A question of self-preservation: immunopathology in influenza virus infection
Nicole L. La Gruta et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
Fernando A. Bozza et al.
CRITICAL CARE (2007)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
